Newbury Pharmaceuticals

Newbury enters the Nordic hospital market through a strategic partnership with a global pharmaceutical company. The partnership is based on an ambition of expanding the portfolio of medicines to become a key player in the hospital segment and can consist of branded and non-branded products.

Newbury is getting access to a portfolio of hospital products from this new strategic partnership where Newbury will represent the global pharmaceutical partner in the Nordic region. The partnership will initially focus on registration of a few selected products which will be launched in line with approval from the authorities.

“We are excited to announce this partnership which is a testimony to our strategic ambition of being a local champion and alternative partner to global players in the Nordic region. Furthermore, we gain access to a variety of products which over time can be registered in the Nordics. This is a blue-print of Newbury as a trusted and committed partner and we look forward to unfold this new segment to our business.”.

The new strategic partnership is expected to contribute with sales growth after the regulatory approvals have been obtained during 2024/2025 and is based on a distribution agreement with limited future investments for Newbury.